Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis and incomplete lower esophageal sphincter relaxation

Neurogastroenterology and Motility

Volumn 23, Issue 2, 2011, Pages

  Porter, R F ^a   Gyawali, C P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Botulinum toxin; Dysphagia; Lower esophageal sphincter relaxation error

Indexed keywords

BOTULINUM TOXIN;

ADULT; AGE DISTRIBUTION; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGUS ACHALASIA; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; SURVIVAL; THORAX PAIN; TREATMENT OUTCOME;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DEGLUTITION DISORDERS; ESOPHAGEAL SPHINCTER, LOWER; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MANOMETRY; MIDDLE AGED; MUSCLE RELAXATION; OUTCOME ASSESSMENT (HEALTH CARE); PERISTALSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78651449997     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01604.x     Document Type: Article

References (24)

1. Mittal RK, Balaban DH. The esophagogastric junction. N Engl J Med 1997; 336: 924-32.
2. Gonzalez AA, Farre R, Clave P. Different responsiveness of excitatory and inhibitory enteric motor neurons in the human esophagus to electrical field stimulation and to nicotine. Am J Physiol Gastrointest Liver Physiol 2004; 287: G299-306.
3. Goyal RK, Rattan S. Nature of the vagal inhibitory innervations to the lower esophageal sphincter. J Clin Invest 1975; 55: 1119-26.
4. Yamato S, Spechler SJ, Goyal RK. Role of nitric oxide in esophageal peristalsis in the opossum. Gastroenterology 1992; 103: 197-204.
5. Raymond L, Lach B, Shamji FM. Inflammatory aetiology of primary oesophageal achalasia: an immunohistochemical and ultrastructural study of Auerbach's plexus. Histopathology 1999; 35: 445-53.
6. Sifrim D, Janssens J, Vantrappen G. Failing deglutitive inhibition in primary esophageal motility disorders. Gastroenterology 1994; 106: 875-82.
7. Clouse RE, Diamant NE. Esophageal motor and sensory function and motor disorders of the esophagus. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 8th edn. Philadelphia: Saunders, 2006: 855-904.
8. Blasi J, Chapman ER, Link E et al. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993; 365: 774-8.
9. Pasricha PJ, Ravich WJ, Hendrix TR et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995; 322: 774-8.
10. Prakash C, Freedland KE, Chan MF, Clouse RE. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approach. Am J Gastroenterol 1999; 94: 328-33.
11. Gui D, Rossi S, Runfola M, Magalini SC. Review article: botulinum toxin in the therapy of gastrointerstinal motility disorders. Aliment Pharmacol Ther 2003; 18: 1-16.
12. Mandal A, Robinson RJ. Indications and efficacy of botulinum toxin in disorders of the gastrointestinal tract. Eur J Gastroenterol Hepatol 2001; 13: 603-9.
13. Miller LS, Parkman HP, Schiano TD et al. Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Dig Dis Sci 1996; 41: 2025-31.
14. Storr M, Allescher HD, Rösch T, Born P, Weigert N, Classen M. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointest Endosc 2001; 54: 754-9.
15. Miller LS, Pullela SV, Parkman HP et al. Treatment of chest in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol 2002; 97: 1640-6.
16. Reidel WL, Clouse RE. Variations in clinical presentation of patients with esophageal contraction abnormalities. Dig Dis Sci 1985; 30: 1065-71.
17. Staiano A, Clouse RE. Detection of incomplete lower esophageal sphincter relaxation with conventional point-pressure sensors. Am J Gastroenterol 2001; 96: 3258-67.
18. Clouse RE, Staiano A. Contraction abnormalities of the esophageal body in patients referred to manometry A new approach to manometric classification. Dig Dis Sci 1983; 28: 784-91.
19. Richter JE, Wu WC, Johns DN et al. Esophageal manometry in 95 healthy adult volunteers Variability of pressures with age and frequency of "abnormal" contractions. Dig Dis Sci 1987; 32: 583-92.
20. Leite LP, Johnston BT, Barrett J, Castell JA, Dastell DO. Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci 1997; 42: 1859-65.
21. Matthew S, Cohen H, Kline M.Botulinum toxin injection improves symptomatic hypertensive lower esophageal sphincter. Gastroenterology 1998; 114: A800.
22. Prabhakar A, Levine MS, Rubesin S, Laufer I, Katzka D. Relationship between diffuse esophageal spasm and lower esophageal sphincter dysfunction on barium studies and manometry in 14 patients. AJR 2004; 183: 409-13.
23. Borjesson M, Pilhall M, Eliasson T, Norssell H, Mannheimer C, Rolny P. Esophageal visceral pain sensitivity: effects of TENS and correlation with manometric findings. Dig Dis Sci 1998; 43: 1621-8.
24. D'Onofrio V, Annese V, Miletto P et al. Long-term follow-up of achalasic patients treated with botulinum toxin. Dis Esophagus 2000; 13: 96-101.